Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications — Stella

View on ClinicalTrials.gov

Recruiting

Back to Lymphoma trials

Trial locations(1 site)

Canada

Sunnybrook Health Sciences Centre, Toronto, Ontario

Key details

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

The Leukemia and Lymphoma Society, Queen's University

Enrollment target

~188 participants

Started

August 2019

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

60 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.